Nanovesicular Formulations for Cancer Gene Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Gene therapy is an emerging cancer treatment strategy utilizing immunologic and molecular methods.
• Efficient gene delivery systems are critical for molecular cancer gene therapy.
• Cationic vesicles, including liposomes and niosomes, are promising nanocarriers for gene delivery.

Purpose of the Study:

• To review the potential of cationic nanocarriers in cancer gene therapy.
• To focus on the role of liposomes and niosomes as vesicular gene delivery devices.
• To provide a collection of representative investigations on cationic nanocarriers for cancer.

Main Methods:

• Literature review of cationic nanocarriers for cancer gene therapy.
• Analysis of liposomes and niosomes as vesicular devices for gene delivery.
• Focus on factors affecting gene delivery, such as composition and physical-chemistry characteristics.

Main Results:

• Cationic vesicles effectively complex with anionic genetic molecules.
• Gene delivery occurs via the endosomal pathway.
• Vesicle composition significantly impacts physical-chemistry properties and transfection efficiency.

Conclusions:

• Cationic liposomes and niosomes are promising nanocarriers for cancer gene therapy.
• Optimizing nanocarrier composition is key to enhancing gene delivery effectiveness.
• Further research into these cationic nanocarriers can advance cancer treatment strategies.